COMMUNIQUÉS West-GlobeNewswire

Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026
23/07/2026
JUPITER, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report second quarter 2026 financial results on Thursday, August 6, 2026. The company will [...]
OKYO Pharma Announces Purchase of Shares by Chief Executive Officer
23/07/2026
LONDON and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
ZoomRx Launches Signal-IQ: Competitive Field Intelligence, Delivering Real-Time NPI-Level Visibility into Competitor Sales Force Activity for Pharma Commercial Teams
23/07/2026
BOSTON, July 23, 2026 (GLOBE NEWSWIRE) -- ZoomRx, a strategic life sciences consultancy trusted by 100+ leading biopharma companies across the world, today announced the launch of Signal-IQ: Competitive Field [...]
Commure Wins Two Stevie® Awards for Technology Excellence, Including Gold for Company of the Year in Healthcare Technology
23/07/2026
CEO Tanay Tandon honored as Executive of the Year MOUNTAIN VIEW, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Commure , the leading AI-native healthcare RCM & Ambient platform, today announced it has been recognized [...]
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC® Technology Platforms and Portfolio
23/07/2026
ZURICH, SWITZERLAND, July 23, 2026 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the appointment of Christoph Erkel, Ph.D., as [...]
NMD Pharma Announces Publication Identifying Neuromuscular Junction Transmission Failure as a Novel Contributor to Age-Related Muscle Weakness
23/07/2026
New publication identifies neuromuscular junction transmission failure as a novel mechanism contributing to sarcopenia, with preclinical studies showing that ClC-1 inhibition improves neuromuscular transmission and [...]
Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing
23/07/2026
Healthcare Holding Schweiz AG, a leading Swiss service provider and distributor of medical technology, has successfully closed a CHF 80 million syndicated financing. Healthcare Holding Schweiz is managed by Winterberg [...]
Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm
23/07/2026
Sòphia High Tech designs and manufactures ROMAN units for the remote inspection and maintenance of the RFX-mod2 fusion experiment, combining its precision manufacturing capabilities with the robotics expertise of [...]
CLINUVEL implements strategic reorganisation to refocus on U.S. markets
23/07/2026
MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January [...]
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc
23/07/2026
Group sales were +6% at constant exchange rates (CER) 1 , -2% when reported in CHF and +8% in USD 2 , in the first six months, driven by high demand for innovative medicines and diagnostics. Pharmaceuticals Division [...]
NMD Pharma Announces Publication Identifying Neuromuscular Junction Transmission Failure as a Novel Contributor to Age-Related Muscle Weakness
23/07/2026
New publication identifies neuromuscular junction transmission failure as a novel mechanism contributing to sarcopenia, with preclinical studies showing that ClC-1 inhibition improves neuromuscular transmission and [...]
argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update
23/07/2026
Strong second quarter performance with $1.5 billion in global product net sales, representing 60% year-over-year growth and 17% quarter-over-quarter growth Successfully launched VYVGART and VYVGART Hytrulo in anti-AChR [...]
Serina Therapeutics Appoints Farrell Simon to its Board of Directors
22/07/2026
HUNTSVILLE, Ala., July 22, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the “Company”) (NYSE American: SER), a clinical-stage biotechnology company advancing its proprietary POZ Platform ™ drug [...]
The Lundquist Institute Launches the Nation's First Adult Exercise Medicine Fellowship
22/07/2026
New physician fellowship, leadership of the Academy of Exercise Medicine, and groundbreaking scientific research position The Lundquist Institute at the forefront of the emerging field of Exercise Medicine. Los Angeles [...]
Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026
22/07/2026
ROCKVILLE, Md., July 22, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
Hundreds of leaders, experts and organisations urge future UN Secretary-General to commit, act and deliver on gender equality as the United Nations faces historic test
23/07/2026
LONDON, July 23, 2026 (GLOBE NEWSWIRE) -- As of today, over 200 current and former heads of state, UN leaders, organisations, advocates, practitioners, and researchers from all regions of the world are calling on the [...]
Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026
22/07/2026
REDWOOD CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc . (Nasdaq: CHRS), today announced that its second quarter 2026 financial results will be released on Wednesday, August 5, 2026. Starting at 5 [...]
The Healing Well Method Launches Chronic Illness Education Initiative to Empower Women with Chronic Illness
22/07/2026
Fort Lauderdale, FLORIDA, July 22, 2026 (GLOBE NEWSWIRE) -- The Healing Well Method today announced the launch of its Chronic Illness Education Initiative, a new educational program designed to help women living with [...]
Serenity Medical’s River Stent™ Demonstrates Sustained 4- to 5-Year Benefits in Patients with Idiopathic Intracranial Hypertension (IIH), Presented at SNIS Annual Meeting in Late-Breaking Session
22/07/2026
Long-term data reinforce durability of venous sinus stenting as an evidence-backed, FDA-approved treatment option MAPLE GROVE, Minn., July 22, 2026 (GLOBE NEWSWIRE) -- Serenity Medical , a NeuroTechnology Investors (NTI [...]

Pages